Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Alena Adamíková"'
Autor:
Alena Adamíková
Publikováno v:
Interní medicína pro praxi. 21:62-66
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ed61e8e04041d5a2dab697b784eaaaf
https://doi.org/10.36290/int.2019.011
https://doi.org/10.36290/int.2019.011
Publikováno v:
Journal of Clinical Laboratory Analysis
Background: The aim of the study was to analyze the degree of obesity and its associations with age, gender, inflammation, an estimated glomerular filtration rate (eGFR), and liver function in type 2 diabetes mellitus (T2DM) patients. Methods: A tota
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca0631d9cdab31b3a60e252973b4471b
https://doi.org/10.1002/jcla.23229
https://doi.org/10.1002/jcla.23229
Autor:
Tomáš Šálek, Alena Adamíková
Publikováno v:
Basic & Clinical Pharmacology & Toxicology
The aim of this study was to provide evidence for the hypothesis that estimated glomerular filtration rate from serum Cystatin C (eGFRcys) is better to be determined for all elderly type 2 diabetes mellitus (T2DM) patients based on eGFRcys upward and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69046fcff64d6136d275d4281e3e1331
http://europepmc.org/articles/PMC7379635
http://europepmc.org/articles/PMC7379635
Publikováno v:
Vnitřní lékařství. 64:357-366
Introduction GLP1 receptor agonist lixisenatide has demonstrated its efficacy in numerous clinical trials, nevertheless its real-life effectiveness data is limited. Aim To describe effectiveness and safety of lixisenatide in routine clinical practice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3ea6b2b1dc47283336e76116ea2b357
https://doi.org/10.36290/vnl.2018.053
https://doi.org/10.36290/vnl.2018.053
Autor:
Alena Adamíková Ph.D
Publikováno v:
Interní medicína pro praxi. 18:103-106
Kanagliflozin patři mezi selektivně ucinkujici inhibitory spolecneho transporteru pro sodik a glukozu SGLT2. Snižuje glykemii blokadou reabsorpce glukozy v ledvinach a sniženim renalniho prahu. Zvýsena glykosurie je spojena s redukci hmotnosti p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1c6d5455e14c30e6b11ca984977769b
https://doi.org/10.36290/int.2016.025
https://doi.org/10.36290/int.2016.025
Autor:
Alena, Adamíková
Publikováno v:
Vnitrni lekarstvi. 62(11 Suppl 4)
Determination of the diagnosis of diabetes mellitus means a radical life change for a patient. Education of a patient with diabetes means the provision of essential information and practical guidance for linkage of the disease with the life style of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c163485654a13aa69644d6181aa1d114
https://pubmed.ncbi.nlm.nih.gov/27921421
https://pubmed.ncbi.nlm.nih.gov/27921421
Autor:
Alena, Adamíková
Publikováno v:
Vnitrni lekarstvi. 62(7-8)
Chronic long term hyperglycemia plays a key role in the pathogenesis of micro and macrovascular complications. The UKPDS study and its further analysis has proved that reduction of the value of glycated hemoglobin by 1 % leads to a 14 % reduction of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ab7e92c7d7db9e0aa894e62731034224
https://pubmed.ncbi.nlm.nih.gov/27627074
https://pubmed.ncbi.nlm.nih.gov/27627074
Autor:
Alena, Adamíková
Publikováno v:
Vnitrni lekarstvi. 61(11)
Type 2 diabetes mellitus is a heterogeneous disease that requires a personalized approach to treatment with goals tailored to capabilities and abilities of the patient, his other diseases so as to ensure good diabetes control without the risk of hypo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9e260a0d17bcf24f42d52e8440a6639d
https://pubmed.ncbi.nlm.nih.gov/26652788
https://pubmed.ncbi.nlm.nih.gov/26652788
Autor:
Alena, Adamíková
Publikováno v:
Vnitrni lekarstvi. 61(4)
The incretin hormone GLP1 (glucagon-like peptide 1) has also systemic effects besides its effects on the pancreas. The renal expression for the receptors GLP1 and DPP4 has been described in a whole line of experimental stu-dies. Activation of the rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::df2668662311b613e4d5e3e3537a1233
https://pubmed.ncbi.nlm.nih.gov/25894260
https://pubmed.ncbi.nlm.nih.gov/25894260
Autor:
Alena, Adamíková
Publikováno v:
Vnitrni lekarstvi. 61(2)
The main cause of renal failure is diabetic nephropathy which affects 20-40 % of diabetic patients. Diabetics with altered renal function have restricted therapeutic options due to the risk of accumulation of oral antidiabetic drugs and of their meta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cee739ad0bff45b83d39431507a73199
https://pubmed.ncbi.nlm.nih.gov/25813259
https://pubmed.ncbi.nlm.nih.gov/25813259